ClinicalTrials.Veeva

Menu
L

Leavitt Clinical Research | Idaho Falls, ID

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

TAK-279
BAY3427080
LPRI-
Elinzanetant
IW-3300
Boric Acid
S-217622

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 19 total trials

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoria...

Enrolling
Plaque Psoriasis
Drug: TAK-279

The objective of this study is to determine clinical cure rate and safety of a proprietary Vaginal Cooling Device (VCD) in women with VCC. In additio...

Enrolling
Yeast Vaginitis
Vulvovaginal Candidiasis (VVC)
Device: vaginal cooling device

This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.

Enrolling
Vulvovaginal Candidiasis (VVC)
Vulvovaginal Candidiasis, Genital
Other: Placebo
Drug: Boric acid

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...

Active, not recruiting
COVID-19
Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
Other: Placebo

Trial sponsors

Abbott logo
Sanofi logo
Takeda logo
Aussie Bubs logo
Bayer logo
C
I
Ironwood Pharmaceuticals logo
Novavax logo
Organon logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems